OpenEvidence
OpenEvidence is a Healthcare Foundation Models company founded in 2022 and based in Miami, United States.
OpenEvidence was founded in 2022 and is headquartered in Miami, United States. Co-founder and CEO Daniel Nadler leads the company, which is privately held. Its product, also named OpenEvidence, is an AI clinical assistant for physicians that answers questions on diagnosis, treatment, and drug information at the point of care, with each response linked to its sources in peer-reviewed medical literature and major journals. The service is free for verified US physicians and is supported by advertising from pharmaceutical and medical-device companies; the company states that sponsored content is kept separate from clinical answers. The company's funding history is not disclosed in this profile.
OpenEvidence applies foundation-model question answering to clinical decision support, returning answers tied to peer-reviewed sources rather than unsourced text. Its primary users are physicians, and the product is built for use at the point of care. The company's adoption among US doctors, which its product description identifies as a defining feature, places it within the healthcare foundation model category. Its advertising-supported model for verified US physicians shows one way such a clinical tool is financed.
At a glance
Total raised
Undisclosed
Headcount
—
Headquarters
Miami
United StatesFounded
2022
Status
Private
Subsector
Funding history
Total raised
—
Rounds tracked
0
No dated funding rounds on file. This company is privately held and may be raising or operating on undisclosed capital.
